Analysed KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) News Sources
RBC Flags Seasonal Pressures Impacting Karyopharm Therapeutics Inc. (KPTI) Short-Term Performance
17-04-2026
yahoo.com
Karyopharm Therapeutics SENTRY Trial Hits Spleen Endpoint, Shows Early Survival Signal in Myelofibrosis
24-03-2026
marketbeat.com
Karyopharm Therapeutics' Blood Cancer Therapy Meets a Key Goal in Phase 3 Study, Plans $30 Million Private Placement
24-03-2026
yahoo.com
Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
24-03-2026
yahoo.com
What is the current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The current price of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is $8.61.
KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) absolute price change since previous trading day?
The absolute price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is $-0.05.
KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) percentage price change since previous trading day?
The percentage price change of KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) since the previous trading day is -0.5774%.
What is the most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The most recent average sentiment score for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is 61 out of 100.
What is the most recent average sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)?
The most recent sentiment for KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ) is .
SEC-8K** Filing Available For KARYOPHARM THERAPEUTICS INC (KPTI:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.